(TULSA, Okla.) — Oklahoma’s attorney general has confirmed that the drugmaker that made billions of dollars selling OxyContin and the company’s owners have reached a $270 million settlement with the state over its role in the opioid crisis.
Attorney General Mike Hunter confirmed the Purdue Pharma settlement at a Tuesday conference in Tulsa.
Nearly $200 million of the Connecticut-based company’s settlement will go toward establishing the National Center for Addiction Studies and Treatment at Oklahoma State University’s health center in Tulsa. Local governments will get $12.5 million.
The deal comes two months before Oklahoma’s lawsuit against Purdue Pharma and other drug companies was set to become the first in a coast-to-coast wave of litigation against the industry to go to trial.
This is the first settlement to come out of the barrage of lawsuits.
